Gambro breaks into Turkey through clinic purchase:
This article was originally published in Clinica
Executive Summary
Swedish company Gambro has bought the Bulten dialysis centre, as well as a local sales company, in Turkey - its first move into this market, where it immediately takes a 10-12% share of the market for dialysis products. "The acquisition is a clear signal that we intend to move into this strategically important market, a market with more patients than Spain and almost as big as France," said Lennart la Fleur, managing director of Gambro Export. Over the past few years, the Turkish dialysis market has been growing at 15% annually.